Cargando…

Targeted proteomics improves cardiovascular risk prediction in secondary prevention

AIMS: Current risk scores do not accurately identify patients at highest risk of recurrent atherosclerotic cardiovascular disease (ASCVD) in need of more intensive therapeutic interventions. Advances in high-throughput plasma proteomics, analysed with machine learning techniques, may offer new oppor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nurmohamed, Nick S., Belo Pereira, João P., Hoogeveen, Renate M., Kroon, Jeffrey, Kraaijenhof, Jordan M., Waissi, Farahnaz, Timmerman, Nathalie, Bom, Michiel J., Hoefer, Imo E., Knaapen, Paul, Catapano, Alberico L., Koenig, Wolfgang, de Kleijn, Dominique, Visseren, Frank L.J., Levin, Evgeni, Stroes, Erik S.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020984/ https://www.ncbi.nlm.nih.gov/pubmed/35139537 http://dx.doi.org/10.1093/eurheartj/ehac055

Ejemplares similares

Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention
por: Hoogeveen, Renate M, et al.
Publicado: (2020)

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Effect of PCSK9 Inhibition on the Plasma Proteome: A SPIRE SubStudy
por: Kraaijenhof, Jordan M., et al.
Publicado: (2023)

The iterative lipid impact on inflammation in atherosclerosis
por: Kraaijenhof, Jordan M., et al.
Publicado: (2021)

Different inflammatory pathways underlying cardiovascular risk in secondary prevention( )
por: Nurmohamed, Nick S, et al.
Publicado: (2022)

Lp(a): a New Pathway to Target?
por: Nurmohamed, Nick S., et al.
Publicado: (2022)

Inflammatory Effects of Triglycerides: Relevant or Redundant?
por: Kraaijenhof, Jordan M., et al.
Publicado: (2023)

Predictive value of targeted proteomics for coronary plaque morphology in patients with suspected coronary artery disease
por: Bom, Michiel J., et al.
Publicado: (2018)

Extracellular Vesicles in Diagnosing Chronic Coronary Syndromes the Bumpy Road to Clinical Implementation
por: Dekker, Mirthe, et al.
Publicado: (2020)

Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
por: Schnitzler, Johan G., et al.
Publicado: (2020)

Considerations for routinely testing for high lipoprotein(a)
por: Nurmohamed, Nick S, et al.
Publicado: (2023)

Comparison of cardiovascular biomarker expression in extracellular vesicles, plasma and carotid plaque for the prediction of MACE in CEA patients
por: Verwer, Maarten C., et al.
Publicado: (2023)

Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability
por: Poels, Kikkie, et al.
Publicado: (2020)

Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases
por: Hoogeveen, Renate M, et al.
Publicado: (2018)

Atorvastatin treatment does not abolish inflammatory mediated cardiovascular risk in subjects with chronic kidney disease
por: Hoogeveen, Renate M., et al.
Publicado: (2021)

Ceramides and phospholipids in plasma extracellular vesicles are associated with high risk of major cardiovascular events after carotid endarterectomy
por: Timmerman, Nathalie, et al.
Publicado: (2022)

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
por: Ballantyne, Christie M, et al.
Publicado: (2019)

Extracellular Vesicle cystatin c is associated with unstable angina in troponin negative patients with acute chest pain
por: Dekker, Mirthe, et al.
Publicado: (2020)

Working towards full eradication of lipid-driven cardiovascular risk?
por: Nurmohamed, N. S., et al.
Publicado: (2021)

Relation Between Circulating Inflammatory Chemokines and Vascular Characteristics in Healthy, Young Children
por: Eikendal, Anouk L. M., et al.
Publicado: (2015)

FoxP1 Stimulates Angiogenesis by Repressing the Inhibitory Guidance Protein Semaphorin 5B in Endothelial Cells
por: Grundmann, Sebastian, et al.
Publicado: (2013)

Cardiovascular risk factor treatment targets and renal complications in high risk vascular patients: a cohort study
por: Selvarajah, Sharmini, et al.
Publicado: (2011)

New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia
por: Pirillo, Angela, et al.
Publicado: (2022)

Molecular Mechanisms Responsible for the Antiinflammatory and Protective Effect of HDL on the Endothelium
por: Norata, Giuseppe D, et al.
Publicado: (2005)

Pre-Emptive OCT-Guided Angioplasty of Vulnerable Intermediate Coronary Lesions: Results from the Prematurely Halted PECTUS-Trial
por: Mol, Jan-Quinten, et al.
Publicado: (2020)

Plasma Testosterone Levels and Atherosclerotic Plaque Gene Expression in Men With Advanced Atherosclerosis
por: Groepenhoff, Floor, et al.
Publicado: (2021)

Circulating levels of P-selectin and E-selectin relate to cardiovascular magnetic resonance-derived aortic characteristics in young adults from the general population, a cross-sectional study
por: Eikendal, Anouk L. M., et al.
Publicado: (2018)

Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries
por: Rosenson, Robert S., et al.
Publicado: (2017)

Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study
por: Ray, Kausik K., et al.
Publicado: (2021)

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases
por: Pirillo, Angela, et al.
Publicado: (2013)

Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3
por: Pirillo, Angela, et al.
Publicado: (2015)

Inclisiran: How Widely and When Should We Use It?
por: Pirillo, Angela, et al.
Publicado: (2022)

Cardiac Function in a Long-Term Follow-Up Study of Moderate and Severe Porcine Model of Chronic Myocardial Infarction
por: de Jong, Renate, et al.
Publicado: (2015)

Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study
por: Nurmohamed, Nick S., et al.
Publicado: (2022)

Combination therapy in cholesterol reduction: focus on ezetimibe and statins
por: Grigore, Liliana, et al.
Publicado: (2008)

Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors
por: Pirillo, Angela, et al.
Publicado: (2021)

Pharmacological and non-pharmacological interventions to influence adipose tissue function
por: Westerink, Jan, et al.
Publicado: (2011)

Blood pressure and cholesterol measurements in primary care: cross-sectional analyses in a dynamic cohort
por: de Boer, Annemarijn R, et al.
Publicado: (2022)

Potent lipoprotein(a) lowering following apolipoprotein(a) antisense treatment reduces the pro-inflammatory activation of circulating monocytes in patients with elevated lipoprotein(a)
por: Stiekema, Lotte C A, et al.
Publicado: (2020)

Gender differences in health-related quality of life in patients undergoing coronary angiography
por: Gijsberts, Crystel M, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_30v6576il1d1h5fccg9l0quir7